|  | Disease-free survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | ||||||
 | N (%) | p-value | p-value | HR | 95% CI | p-value | p-value | HR | 95% CI |
Age at diagnosis | |||||||||
 < 60 | 92 (60.1) | 0.184 | - |  |  | 0.001 | 0.483 | 1.381 | 0.559–3.411 |
 ≥ 60 | 61 (39.9) |  |  |  |  |  |  |  |  |
DM/HTN | |||||||||
 None | 105 (68.6) | 0.455 | - |  |  | 0.115 | _ |  |  |
 DM or HTN | 48 (31.4) |  |  |  |  |  |  |  |  |
Menopause | |||||||||
 no | 55 (35.9) | 0.437 | - |  |  | 0.231 | _ |  |  |
 yes | 98 (64.1) |  |  |  |  |  |  |  |  |
BMI | |||||||||
 < 25 | 102 (66.7) | 0.039 | 0.020 | 1.434 | 1.058–1.945 | 0.043 | _ |  |  |
 ≥ 25 | 51 (33.3) |  |  |  |  |  |  |  |  |
Histologic type | |||||||||
 Serous | 100 (65.4) | < 0.001 | - |  |  | 0.029 | _ |  |  |
 Endometroid | 12 (7.8) |  |  |  |  |  |  |  |  |
 Clear cell | 14 (9.2) |  |  |  |  |  |  |  |  |
 Mucinous | 20 (13.1) |  |  |  |  |  |  |  |  |
 Transitional cell | 3 (1.9) |  |  |  |  |  |  |  |  |
 MMMT | 4 (2.6) |  |  |  |  |  |  |  |  |
Cell type | |||||||||
 Serous | 100 (65.4) | < 0.001 | 0.017 | 2.530 | 1.178–5.433 | 0.001 | 0.716 | 1.238 | 0.390–3.926 |
 Non-serous | 53 (34.5) |  |  |  |  |  |  |  |  |
First-line therapy | |||||||||
 PDS | 135 (88.2) | < 0.001 | 0.049 | 2.017 | 1.000–4.068 | 0.001 | 0.967 | 1.023 | 0.342–3.052 |
 NAC | 18 (11.8) |  |  |  |  |  |  |  |  |
Surgical optimality | |||||||||
 Optimal | 115 (75.2) | < 0.001 | 0.377 | 1.328 | 0.706–2.499 | < 0.001 | 0.295 | 1.573 | 0.673–3.676 |
 Suboptimal | 38 (24.8) |  |  |  |  |  |  |  |  |
FIGO stage | |||||||||
 1 | 49 (32.0) | < 0.001 | 0.009 | 1.571 | 1.116–2.210 | < 0.001 | 0.008 | 2.516 | 1.260–5.024 |
 2 | 8 (5.2) |  |  |  |  |  |  |  |  |
 3 | 71 (46.4) |  |  |  |  |  |  |  |  |
 4 | 25 (16.4) |  |  |  |  |  |  |  |  |
Chemo-response | |||||||||
 Sensitive | 112 (73.2) | < 0.001 | 0.012 | 2.007 | 1.160–3.475 | < 0.001 | 0.027 | 2.786 | 1.121–6.923 |
 Resistant | 20 (13.1) |  |  |  |  |  |  |  |  |
 Unknown | 21 (13.7) |  |  |  |  |  |  |  |  |
tFMR | |||||||||
 < 2.22 | 79 (51.6) | 0.328 | - |  |  | 0.303 | _ |  |  |
 ≥ 2.22 | 74 (48.4) |  |  |  |  |  |  |  |  |
vFMR | |||||||||
 < 0.83 | 86 (56.2) | 0.035 | 0.989 | 0.995 | 0.547–1.812 | 0.002 | 0.014 | 3.302 | 1.269–8.594 |
 ≥ 0.83 | 67 (42.8) |  |  |  |  |  |  |  |  |
SMI | |||||||||
 < 38.7 | 51 (33.3) | 0.583 |  |  |  | 0.051 | _ |  |  |
 ≥ 38.7 | 102 (66.7) |  |  |  |  |  |  |  |  |